| Stephen Guffanti, MD | |
|
740 Nordahl Rd, # 117, San Marcos, CA 92069-3543 | |
| (615) 778-4066 | |
| Not Available |
| Full Name | Stephen Guffanti |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Occupational Medicine |
| Location | 740 Nordahl Rd, San Marcos, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790800936 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083X0100X | Preventive Medicine - Occupational Medicine | A31482 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Stephen Guffanti, MD 2250 Tierra Verde Rd, Vista, CA 92084-6516 Ph: (760) 727-7602 | Stephen Guffanti, MD 740 Nordahl Rd, # 117, San Marcos, CA 92069-3543 Ph: (615) 778-4066 |
News Archive
A team of clinicians and scientists from the National Cancer Centre Singapore (NCCS), Singapore General Hospital (SGH) and A*STAR's Genome Institute of Singapore (GIS) has identified a novel method to treat triple-negative breast cancer (TNBC). They discovered that cancer cells switch between different cell states and are able to change from being less aggressive ('epithelial') to being more aggressive ('mesenchymal'), and vice versa.
Research published by University of Leicester researchers in the top journal "Circulation" identifies a gene that affects blood pressure levels in the general population.
Malvern Panalytical (Malvern Panalytical, UK) and Paraytec Ltd (York, UK) have entered into a development and licensing agreement that will see Paraytec's ActiPix® technology being added to Malvern Panalytical's materials characterization portfolio. The agreement will give Malvern Panalytical exclusive rights to further develop, market and sell ActiPix® UV area imaging technology in specific fields of use related to the characterization of complex fluids for applications in biopharmaceuticals, foods and personal care industrial sectors.
In a study that involved more than 31,000 women who are carriers of disease-associated mutations in the BRCA1 or BRCA2 genes, researchers identified mutations that were associated with significantly different risks of breast and ovarian cancers, findings that may have implications for risk assessment and cancer prevention decision making among carriers of these mutations, according to a study in the April 7 issue of JAMA.
› Verified 6 days ago
Dr. Kate Anna Haggerty, M.D. Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 Craven Rd, San Marcos, CA 92078 Phone: 800-290-5000 | |
Ronald K Shimmin, M.D. Preventive Medicine Medicare: Medicare Enrolled Practice Location: 1146 San Marino Dr, San Marcos, CA 92078 Phone: 760-471-2033 Fax: 760-471-2083 | |
Karen D Nicholson, M.D., M.P.H. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 333 S. Twin Oaks Valley Rd, Cal State San Marcos Shcs, San Marcos, CA 92096 Phone: 760-750-4920 Fax: 760-750-3181 | |
Dr. M J Peters, M.D Preventive Medicine Medicare: Medicare Enrolled Practice Location: 400 Craven Rd, San Marcos, CA 92078 Phone: 800-290-5000 | |
Gordon A Booth, M.D. Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 740 Nordahl Rd, #117, San Marcos, CA 92069 Phone: 615-778-4066 |